Coloplast A/S (OTCMKTS:CLPBY) Sees Strong Trading Volume After Analyst Upgrade

Shares of Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY) saw an uptick in trading volume on Thursday after Sanford C. Bernstein upgraded the stock to a hold rating. 1,386,759 shares were traded during mid-day trading, an increase of 241% from the previous session’s volume of 407,150 shares.The stock last traded at $8.60 and had previously closed at $8.48.

Coloplast A/S Stock Performance

The company has a debt-to-equity ratio of 1.20, a quick ratio of 1.00 and a current ratio of 1.61. The stock’s 50 day moving average price is $8.74 and its 200 day moving average price is $9.13. The company has a market capitalization of $19.40 billion, a P/E ratio of 35.88, a price-to-earnings-growth ratio of 0.82 and a beta of 0.26.

Coloplast A/S (OTCMKTS:CLPBY) last announced its earnings results on Tuesday, November 4th. The company reported $0.07 earnings per share for the quarter, missing analysts’ consensus estimates of $0.09 by ($0.02). The firm had revenue of $1.07 billion for the quarter, compared to the consensus estimate of $1.10 billion. Coloplast A/S had a return on equity of 24.99% and a net margin of 13.01%. As a group, equities analysts expect that Coloplast A/S Sponsored ADR will post 0.31 EPS for the current year.

Coloplast A/S Company Profile

Coloplast A/S is a global developer and manufacturer of medical devices and services focused on intimate healthcare. The company specializes in solutions designed to assist individuals with chronic medical conditions, aiming to improve quality of life through innovative products. Coloplast’s offerings span ostomy care, continence care, wound and skin care, and interventional urology, targeting patients who require long-term support and specialized treatments.

In its ostomy business, Coloplast provides pouches, skin barriers and accessories for patients who have had surgical procedures to divert bodily waste.